 |
l, 1′-[1,4-phenylenebis (methylene)]-bis-1,4,8,11- tetraazacyclotetradecane |
|---|---|
| Trade Name | Mozobil |
| Orphan Indication | Treatment to mobilize progenitor cells prior to stem cell transplantation |
| EU Market Approval | EU |
| EU Designation Date | 2004-10-20 00:00:00 |
| Sponsor | Genzyme Europe B.V. |
